Sodium citrate compound enema
- Drugs List
- Therapeutic Indications
- Dosage
- Contraindications
- Precautions and Warnings
- Pregnancy and Lactation
- Side Effects
- Monograph
Presentation
Enema containing sodium citrate compound
Drugs List
Therapeutic Indications
Uses
Constipation
Preparation for radiological, endoscopic and surgical procedures on colon
Dosage
Adults
Administer the contents of one enema rectally.
Elderly
Administer the contents of one enema rectally.
Children
Children 3 to 18 years
Administer the contents of one enema rectally.
Children 1 month to 3 years
Administer the contents of one enema rectally, but only half the length of the nozzle is inserted into the rectum.
Not all brands are licensed for use in children under 3 years.
Contraindications
Neonates
Acute gastrointestinal disorder
Inflammatory bowel disease
Precautions and Warnings
Children aged 1 month to 3 years
Debilitation
Elderly
Children under 3 years: nozzle should be inserted to half its length only
Not all brands are licensed for children under 3 years
Avoid prolonged use
Advise patient that enema takes 5-10 minutes to work after administration
Pregnancy and Lactation
Pregnancy
Sodium citrate compound enema is indicated for use in constipation in obstetrics.
Lactation
No special recommendations.
Counselling
Administration instructions are as follows:
1. Lie down on your side with your knees drawn up towards your tummy, or sit on the toilet.
2. Pull or twist the cap off the tube.
3. If necessary lubricate nozzle by squeezing a drop of liquid onto the end of the nozzle.
4. Insert the full length of the nozzle into your back passage.
5. Gently squeeze the tube until empty.
6. Keep squeezing tube as you pull the nozzle out (this is to prevent the medicine being drawn back into the tube).
7. Wait for the laxative to take effect (5 to 10 minutes).
Side Effects
Abdominal pain
Anal irritation
Cramp
Diarrhoea/loose stools
Hypersensitivity reactions
Rectal discomfort
Tenesmus
Overdosage
It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.
The following number will direct the caller to the relevant local centre (0844) 892 0111
Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).
Further Information
Last Full Review Date: November 2016
Reference Sources
Joint Formulary Committee. British National Formulary. 72nd ed. London: BMJ Group and Pharmaceutical Press; 2016.
Paediatric Formulary Committee. BNF for Children 2016-2017. London: BMJ Group, Pharmaceutical Press, and RCPCH Publications; 2016.
Summary of Product Characteristics: Micolette Micro-enema. Pinewood Laboratories Ltd. Revised June 2015
Summary of Product Characteristics: Micralax Micro-enema. RPH Pharmaceuticals. Revised May 2015
Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content
FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.